Axio Biosolutions Revenue and Competitors

Location

$21M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Axio Biosolutions's estimated annual revenue is currently $17.7M per year.(i)
  • Axio Biosolutions's estimated revenue per employee is $96,875
  • Axio Biosolutions's total funding is $21M.

Employee Data

  • Axio Biosolutions has 183 Employees.(i)
  • Axio Biosolutions grew their employee count by -11% last year.

Axio Biosolutions's People

NameTitleEmail/Phone
1
VP Sales (India)Reveal Email/Phone
2
Head DesignReveal Email/Phone
3
Head – R&DReveal Email/Phone
4
Director – FinanceReveal Email/Phone
5
Senior Manager – HRReveal Email/Phone
6
Area Business ManagerReveal Email/Phone
7
Project Manager -R&DReveal Email/Phone
8
Co FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M155-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M1068%N/AN/A
#5
$9.5M12310%N/AN/A
#6
$21.2M2738%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M2445%N/AN/A
#9
$12.5M1619%N/AN/A
#10
$20.5M2648%N/AN/A
Add Company

What Is Axio Biosolutions?

Axio is a deep science medtech company focused on Advanced Surgical, Trauma and woundcare. Makers of India's first USFDA cleared hemostat - AXIOSTAT (a patented, Fda 510k and CE approved medical device made from 100% Chitosan) and MaxioCel (a chitosan microfiber dressing for Diabetic foot ulcers and other chronic ulcers) Axio develops and commercializes active medical products using novel biomaterials for advanced woundcare. We believe in creating value by delivering affordable solutions for unmet health care needs.

keywords:Healthcare, Medical Devices, Defense, Hospitals

$21M

Total Funding

183

Number of Employees

$17.7M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Axio Biosolutions News

2022-04-06 - Patch Based Wound Healing Products Market, Future Trend ...

... Verpackungsmaschinen GmbH, Sanara MedTech Inc., Reapplix A/S, Cardinal Health, Ostomed, Kerecis, Axio Biosolutions Pvt Ltd, NanoVibronix.

2021-07-27 - Medtech Startup Axio Biosolutions Raises $6 Mn From TrueScale Capital, Existing Investors

Axio Biosolutions, a Boston and Bengaluru-based medical device company has raised $6 Mn in Series B2 led by TrueScale Capital. Existing investors Omidyar Network India, University of California – Ratan Tata Fund, and Accel also participated in this funding round. With this deal, Sameer Nath, man ...

2021-07-27 - Axio Biosolutions raises $6 million in Series B2 round led by TrueScale Capital

In total, Axio has raised over $20 million till date Med-tech company Axio Biosolutions has raised $6 million in a Series B2 equity raise led by TrueScale Capital. Existing investors such as Omidyar Network India, University of California–Ratan Tata Fund, and Accel also participated in the roun ...

2021-07-27 - Axio Biosolutions raises $6 million in funding led by Truescale Capital

ETtechIllustration: Rahul Awasthi Medical technology company Axio Biosolutions on Tuesday said it has raised $6 million (about Rs 45 crore) in a funding round led by Truescale Capital. Existing investors Omidyar Network India, University of California-Ratan Tata Fund, and Accel also participate ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.1M1835%N/A
#2
$33.2M1833%N/A
#3
N/A1846%N/A
#4
$16.4M18650%N/A
#5
$14.8M18617%N/A